RIN Institute
Date | Investors | Amount | Round |
---|---|---|---|
N/A | Spinout | ||
N/A | JPY28.0m | Seed | |
N/A | JPY99.0m | Series A | |
N/A | JPY3.0m | Early VC | |
JPY201m | Late VC | ||
N/A | JPY50.0m | Series B | |
JPY200m | Late VC | ||
N/A | - | ||
$3.6m | Late VC | ||
Total Funding | CAD11.1m |
Related Content
Recent News about RIN Institute
EditRinmab Co., Ltd. specializes in providing advanced research and development (R&D) solutions tailored for medical and exclusive associations. Operating within the niche market of medical research, the company focuses on enhancing the capabilities of its clients through cutting-edge technology and expert advisory services. Rinmab serves a diverse clientele, including national research institutes and specialized medical associations, aiming to drive innovation and development in the medical field. The business model revolves around offering bespoke R&D services, consultancy, and technological solutions that cater to the unique needs of its clients. Revenue is generated through service contracts, consultancy fees, and long-term partnerships with research institutions. Rinmab's commitment to advancing medical research positions it as a key player in the industry, fostering growth and innovation.
Keywords: R&D solutions, medical research, exclusive associations, consultancy, technology, innovation, development, niche market, advisory services, partnerships.